Community acquired pneumonia A/Prof Peter Wark Department of Respiratory and Sleep Medicine John Hunter Hospital.

Slides:



Advertisements
Similar presentations
Pneumonia SAHD Senior Academic Half Day Matt Rogers & James Clayton
Advertisements

Antimicrobial Prescribing in the Management of COPD
Chest Infections Lawrence Pike.
Yong Lee ICU Registrar John Hunter Hospital
ד"ר אורי לקסר מכון הראה בית החולים האוניברסיטאי הדסה
Community Acquired Pneumonia Guidelines 2011 Top 11 Recommendations Michael H. Kim.
SEPSIS KILLS program Adult Inpatients
What is Pneumonia and How Do I Prevent it?
Microbiology Nuts & Bolts Test Yourself Session 1 Begin here.
1 Acute Cough Definitions of Lower Respiratory Tract Infections (LRTI), ranging in severity: Acute bronchitis - an acute respiratory tract infection in.
Clinical Knowledge Summaries CKS Chest infections - adults
Outline  Diagnosis of CAP  Site of care?  Tools for risk assessment?  Diagnostic tests needed?  Management of severe CAP ? Community-Acquired Pneumonia:
Nikola Bla ž evi ć Mentor: A. Ž mega č Horvat. - inflammation of the lungs caused by infection - many different causes: bacteria, viruses, fungi, idiopathic.
Pneumonia Why do we need to know about it? Long recognized as a major cause of death, Pneumonia has been studied intensively since late 1800s. Despite.
CPC # 2 Infectious Disease October 7, 2008 Lisa L. Maragakis, MD MPH.
Lower Respiratory Tract Infection. Pneumonia Common with high morbidity and mortality rates. Acute respiratory infection with focal chest signs and radiographic.
Pam Charity, MD Cathryn Caton, MD, MS.  Define pneumonia  Review criteria for diagnosis  Review criteria for admission  Review treatment options.
PATIENT TYPEETIOLOGY OutpatientStreptococcus pneumoniae Mycoplasma pneumoniae Haemophilus influenzae Chlamydophila pneumoniae Respiratory viruses* Non-ICU.
Bacterial Pneumonia Sung Chul Hwang, M.D. Dept. of Pulmonary and Critical Care Medicine Ajou University School of Medicine.
A case of haemoptysis ERWEB Case.
Pneumonia and Sepsis By Oliver Putt and Priyanca Patel For WMS Peer Support – 11 th November 2014.
Lower Respiratory Tract Infections in Children Abdelaziz Elamin Professor of Child Health University of Khartoum Sudan.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
Dr A.J.France © A.J.France Objectives  Define the range of conditions  Recognise the common clinical presentations  Understand the significance.
Bronchitis, Pneumonia, and Pleural Empyema
1 Respiratory Diseases in HIV-infected Patients HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Julio A. Ramirez, MD, FACP Professor of Medicine Chief, Infectious Diseases University of Louisville Chief, Infectious Diseases Veterans Affairs Medical.
Plans for Diagnosis of Community Acquired Pneumonia.
Patient presenting with altered mental status
Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2.
Serum procalcitonin and C-reactive protein in children with community- acquired pneumonia K.Gogvadze, I.Guramishvili, I.Chkhaidze, K.Nemsadze, T.Maglakelidze.
Hot Topic Meeting by: Royal College of Physicians of Edinburgh & The Scottish Executive Health Department Pandemic Flu Planning Scotland’s Health Response.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division under the supervision and administration.
Diagnostic Criteria: Severe Community-Acquired Pneumonia Antonio Anzueto The University of Texas Health Science Center at San Antonio, Texas.
A 41 year old man known case of DM presents with 2 day history of productive cough, fever and associted with pleuritic chest pain. His cough is productive.
Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2.
 What are the signs to diagnose severe pneumonia?  Enumerate 4 organisms for community acquired pneumonia.
Antibiotics 101 A review of common infections and their treatment For others, like me, who have a mental block against all things related to antibiotics.
Pneumonia Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Introduction Infection involving the.
Diagnosis, Empiric Management and Prevention of CAP
LRTIs and Sepsis Poppy. Bronchitis/Pneumonia Bronchitis ▫Infection & inflammation of airways Pneumonia ▫Infection & inflammation of alveoli.
Risk factors for severe disease from pandemic (H1N1) 2009 virus infection reported to date are considered similar to those risk factors identified for.
Community Acquired Pneumonia (CAP)
بسم الله الرحمن الرحيم. BronchiolitisBronchiolitis By Hana ’ a M.N. Tashkandi.
R3 정수웅. Introduction Community-acquired pneumonia − Leading infectious cause of death in developed countries − The mortality in patients with treatment.
폐렴으로 오인할 수 있는 폐렴 외 질환 호흡기 내과 R3 최 문 찬.
Community-Acquired Pneumonia Richard G. Wunderink, M.D., and Grant W. Waterer, M.B., B.S., Ph.D. N Engl J Med 2014;370: R3 김선혜 /Prof. 박명재 1.
Community Acquired Pneumonia. Definitions Community acquired pneumonia (CAP) – Infection of the lung parenchyma in a person who is not hospitalized or.
Comparison between pathogen directed antibiotic treatment and empiri cal broad spectrum antibiotic treatment in patients with community acquired pneumonia.
PNEUMONIA DR. FAWAD AHMAD RANDHAWA M.B.B.S. ( KING EDWARD MEDICAL COLLEGE) M.C.P.S; F.C.P.S. ( MEDICINE) F.C.P.S. ( ENDOCRINOLOGY) ASSISTANT PROFESSOR.
Time for first antibiotic dose is not predictive for the early clinical failure of moderate–severe community-acquired pneumonia Eur J Clin Microbial Infect.
APIC Chapter 13 Journal Club March 16, 2015 Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults NEJM – July 30, :5 Presented.
Clinical Knowledge Summaries CKS Chest infections - adults Primary care management of acute bronchitis and community-acquired pneumonia in adults. Infective.
PNEUMONIA COMMUNITY-ACQUIRED PNEUMONIA. RESPIRATORY INFECTIONS URTI – common cold, usually viral. Pharyngitis, tracheitis, rhinitis,sinusitis LRTI – Lower.
Thank you for viewing this presentation.
Pneumonia.
More Antibiotics Tutoring
Infective endocarditis
Pneumonia Salutations:
Community Acquired Pneumonia Tutoring
Dr Asmaa fathy abdellah hassan
Prof Frank Peters Dept Family Medicine University of Pretoria
PHARMACOTHERAPY III PHCY 510
CAP Irfan Shafi  PGY 1  1885,  Dr. Holtzapple administered oxygen to 16-year-old Pt with pneumonia.
CAP Therapy Babak Sayad Associate Professor of Infectious Diseases
COPD Exacerbations UCI Internal Medicine Mini-Lecture
CLINICAL PROBLEM SOLVING
Ordering Sputum Cultures in Community Acquired Pneumonia
Community Acquired Pneumonia
Empiric antibiotic therapy
Presentation transcript:

Community acquired pneumonia A/Prof Peter Wark Department of Respiratory and Sleep Medicine John Hunter Hospital

Ms AN, 37 year old Previously well 3 day history –Sore throat –Dry cough Today –Left sided sharp chest pain –Felt hot and unwell, rigors

Differential diagnosis Pneumonia Bronchitis Asthma Pulmonary embolus

Epidemiology In US pneumonia –6 th leading cause of death –Leading cause of death from an infectious disease Mortality –1-5% –Up to 40%

Identifying a pathogen

In clinical practice an organism is found in only 50% No single test is available that can identify all organisms History, clinical findings and X-ray changes are not diagnostic of a particular organism ? Mixed infection, especially viral and bacterial

CAP, no history of significant chronic disease 20-60%, Strep Pneumoniae 3-37%, Mycoplasma Pneumoniae and Chlamydia Pneumoniae 10% cases –Viral (exceptions influenza, adenovirus) –Staph Aureus (MSSA and MRSA) –Gram neg organisms –Legionella pneumophilia (3-10%)

CAP and co-morbid diseases Risk is increased –Nursing home resident –Cardiorespiratory disease (COPD, CCF) –Immunosuppression –Alcoholism –Recent antibiotic use –Age > 65 years Cause –more gram negative organisms or resistant pathogens –Viral (CMV, VSZ, respiratory viruses –PCP –Fungal

Severe CAP 20-50%, Strep Pneumoniae 10-30% E.Coli, K Pneumoniae, Enterobacter 3-10% Legionella pneumophilia (adm ICU) Staph Aureus – MSSA –MRSA Viral Pseudomonas Aerugniosa ?

Viral pneumonia PCR improves detection Some series, accounts for up to 24% Not predicted by CXR or CRP Pathogens –Influenza –SARS –RSV –Rhinovirus (co-pathogen 35% severe CAP) –Adenovirus

How to identify the pathogen?

Sputum Sensitivity 10-54% “good sample” and cultured quickly Gram stain positive (esp Pneumococcus) Culture best with heavy growth and correlation with gram stain Special culture medium for Legionella, sensitivity % (better with BAL), specificity 80% High false positive, especially Staph Aureus & GNB

Blood cultures Sensitivity 7-16%, specificity 90% (depends on organism) Strep Pneumoniae, –accounts for 2/3 positive blood cultures –Pneumococcal bacteraemia, 1%, mortality 19% vs 4% hospitalised with pneumococcal pneumonia

Urinary antigens Detection of Strep Pneumoniae & Legionella Advantages –Easily available –Valid after antibiotics initiated Pneumococcus –Sensitivity 82%, specificity 97% (bacteraemic) Legionella –Sensitivity 70-80%, specificity 97% –Only L. Pneumophilia

Severity scoring CURB-65 –Confusion (1 point) –Urea >7mmols (1) –Respiratory rate >30 (1) –BP, systolic <90 or diastolic < 60 (1) –Age >65yrs ScoreImplication 0-1Risk death <3%, OP Risk death 9% hospitalise Mortality 15-40% consider ICU

PSI in adults Sex M (0 points) F (-10 points) Demographic factors Age (1 point for each year) Nursing home resident (10 points) Comorbid illnesses Neoplastic disease (30 points) Liver disease (20 points) Congestive heart failure (10 points) Cerebrovascular disease (10 points) Renal disease (10 points) Physical examination findings Altered mental status (20 points) Respiratory rate >= 30/minute (20 points) Systolic blood pressure < 90 mmHg (20 points) Temperature = 40 degrees C (15 points) Pulse >= 125/minute (10 points)

PSI in adults Laboratory and radiographic findings Arterial pH < 7.35 (30 points) Blood urea nitrogen >= 30 mg/dL (11 mmol/L) (20 points) Sodium < 130 mEq/L (20 points) Glucose 14 mmol/L) (10 points) Hematocrit < 30 percent (10 points) Partial pressure of arterial oxygen < 60 mmHg or oxygen saturation < 90% (10 points) Pleural effusion (10 points) 0-50 Points:Class I 0.1% Mortality Points:Class II 0.6% Mortality Points:Class III 0.9% Mortality Points:Class IV 9.3% Mortality Points:Class V 27.0% Mortality

PSI and assessment

Assessment; co-morbidities Age >65yrs Chronic disease –COPD –CCF –Diabetes –Liver disease –Chronic renal failure –Neoplasia Alcoholism Immunosuppression

Assessment examination Altered mental state Tachypnoea (RR>30) Hypotension (systolic <90mmHg) Temperature 40 o C Tachycardia (125bpm)

Assessment, investigations Electrolytes –Na <130mmol –Glucose >14mmol Renal impairment (Urea >11mmol/L) Gas exchange and acid base –pH <7.35 –PaO 2 <60mmHg CXR –Extent consolidation –Presence of an effusion

Ms AN ClinicalInvestigations Age 39 years No co-morbidities Altered mental state BP 100/50 Temp, 39.5 RR, 32bpm HR 125 pH 7.38 pO2 68mmHg Na 135mmols HCT 32% Urea 8mmols BGL 8mmols No effusion Score 104 Class 4 mortality 9.3%

Management

Empirical antibiotics Moderate –Penicillin 1.2g 4hrly IV + –Doxycycline or clarithromycin or azithromycin orally –If gram negative, add gentamicin for 2-3 doses (7mg/kg/d) Severe –Penicillin 1.2g IV 6hrly + –Gentamicin IV 2-3 doses + –Azithromycin 500mg IV Alternate –Ceftriaxone 1g/d or –Tazocin 4.5gm QID –Moxifloxacin 400mg IV/PO daily

Outcomes with empirical antibiotics (Asadi et al Resp Med patients mild pneumonia Those who received guideline based treatment, less likely to die, 6% v 1% (OR 0.23, 0.09 to 0.59) Those who received macrolides (as opposed to fluroquinolones) were less likely to die.

Watching the clinical response

The usual response hrs, see stability Day 3, –improvements in symptoms –Defervescence by day 4 (most rapid Strep Pneumoniae) –Fall in WCC & CRP or 50% reduction PCT CXR –Slow to resolve (60% some abnormality at 4 weeks)

Responders 48 to 72hrs Switch to PO therapy –Improvement in cough and dyspnoea –Afebrile –WCC & CRP improving Discharge No need to repeat CXR now, but 4-6 weeks post discharge

Procalcitonin in CAP PCT >0.25 mcg/L and decision to use antibiotics reduces unnecessary antibiotic use in 2 RCTs –Improves diagnosis in those with heart failure –Cost effective in ICU Higher PCT predicts the presence of bacteraemia Increase in PCT in first 72hrs was associated with reduced survival Fall in PCT by 50% indicates an ability to switch to PO antibiotics

PCT and CURB-65

Progress 24-72hrs clinical response Early clinical response Switch to oral & discharge Lack of clinical response Deteriorating Revaluate Host Pathogen Complications

Failure to respond

Lack of response or deterioration Host factors –Elderly –Immunosuppressed –Bacteraemia –Chronic illness –Diabetes –Alcoholism –Second nosocomial pneumonia Misdiagnosis –Pulmonary embolus –CCF –Pulmonary haemorrhage –Pulmonary vasculitis –BOOP –Acute interstitial pneumonitis –Eosinophilic pneumonia –Hypersensitivity pneumonitis Local factors –Effusion/empyema –Abscess

Called to Ms AN Agitated and very breathless P 140, BP 90/50, RR 38, T 39 0 C ABGs (FiO 2 0.5) –pH 7.32 –PaO 2 55mmHg –PaCO 2 30mmHg –HCO 3 16mmols

Called to see Ms AN Agitated and very breathless P 140, BP 90/50, RR 38, T 39 0 C ABGs (FiO 2 0.5) –pH 7.32 –PaO 2 55mmHg –PaCO 2 30mmHg –HCO 3 16mmols

The cause? Progression of pneumonia ARDS Bacteraemia Shock

Empyema Suspect –Persistent fever –Pleuritic chest pain –Organisms (pneumococcous, Strep Milleri, Staph Aureus) Clinical examination Image again

Empyema

Lung abscess/necrotising pneumonia

Conclusions 1.Clinical assessment –Diagnosis with CXR –Risk factors for poor outcomes –Severity assessment 2.Follow guidelines for empirical antibiotics 3.Assess response 4.Reassess if response is not typical